cynandione-a and Shock--Septic

cynandione-a has been researched along with Shock--Septic* in 1 studies

Other Studies

1 other study(ies) available for cynandione-a and Shock--Septic

ArticleYear
Cynandione A attenuates lipopolysaccharide-induced production of inflammatory mediators via MAPK inhibition and NF-κB inactivation in RAW264.7 macrophages and protects mice against endotoxin shock.
    Experimental biology and medicine (Maywood, N.J.), 2015, Volume: 240, Issue:7

    Cynanchum wilfordii has been traditionally used in eastern Asia for the treatment of various diseases such as gastrointestinal diseases and arteriosclerosis. Cynandione A (CA), an acetophenone, is one of major constituents from roots of C. wilfordii. In the present study, the anti-inflammatory activities of CA were investigated in lipopolysaccharide (LPS)-treated RAW264.7 macrophages and LPS-administered C57BL/6 N mice. CA significantly decreased LPS-induced production of nitric oxide and prostaglandin E2 in a dose-dependent manner, while CA up to 200 μM did not exhibit cytotoxic activity. Our data also showed that CA significantly attenuated expression of iNOS and COX-2 in LPS-stimulated macrophages. CA inhibited phosphorylation of IκB-α and MAP kinases such as ERK and p38. Furthermore, we demonstrated that CA inhibited translocation of NF-κB to the nucleus, transcription of the NF-κB minimal promoter and NF-κB DNA binding activity. Administration of CA significantly decreased the plasma levels of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β in LPS-injected mice and improved survival of septic mice with lethal endotoxemia. These results demonstrate that CA has effective inhibitory effects on production of inflammatory mediators via suppressing activation of NF-κB and MAPK signaling pathways, suggesting that CA may be used as a potential anti-inflammatory agent for the prevention and treatment of inflammatory diseases.

    Topics: Animals; Anti-Inflammatory Agents; Biphenyl Compounds; Blotting, Western; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Inflammation Mediators; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; Plant Extracts; Plant Roots; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Shock, Septic

2015